Cargando…

Circulating tumor cell methylation profiles reveal the classification and evolution of non-small cell lung cancer

BACKGROUND: The ability of circulating tumor cells (CTCs) to identify lung adenocarcinoma (LUAD) and lung squamous cell carcinoma (LUSC) could improve pathological diagnosis and the selection of treatments for non-small cell lung cancer (NSCLC). Previous studies have shown that deoxyribonucleic acid...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jiang, Jia-Hao, Gao, Jian, Chen, Chang-Yue, Ao, Yong-Qiang, Li, Jing, Lu, Yuan, Fang, Wang, Wang, Hai-Kun, de Castro, Douglas Guedes, Santarpia, Mariacarmela, Hashimoto, Masaki, Yuan, Yun-Feng, Ding, Jian-Yong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8902094/ https://www.ncbi.nlm.nih.gov/pubmed/35280307 http://dx.doi.org/10.21037/tlcr-22-50

Ejemplares similares

Circulating tumor cells can predict the prognosis of patients with non-small cell lung cancer after resection: a retrospective study
por: Li, Zhao, et al.
Publicado: (2021)

Tumor immune microenvironment characterization and response to anti-PD-1 therapy
por: Santarpia, Mariacarmela, et al.
Publicado: (2015)

Circulating tumor DNA accurately predicts disease progression and genotype alterations in postoperative adjuvant EGFR-TKI resistance: a case report
por: Zeng, Zhen, et al.
Publicado: (2022)

KRAS driven expression signature has prognostic power superior to mutation status in non‐small cell lung cancer
por: Nagy, Ádám, et al.
Publicado: (2016)

Overview on Therapeutic Options in Uncommon EGFR Mutant Non-Small Cell Lung Cancer (NSCLC): New Lights for an Unmet Medical Need
por: Pretelli, Giulia, et al.
Publicado: (2023)

Tumor-infiltrating CD36(+)CD8(+)T cells determine exhausted tumor microenvironment and correlate with inferior response to chemotherapy in non-small cell lung cancer
por: Ao, Yong-Qiang, et al.
Publicado: (2023)

Increased detection of circulating tumor DNA by short fragment enrichment
por: Liu, Yang, et al.
Publicado: (2021)

Mosaicism in von Hippel-Lindau disease: an event important to recognize
por: Santarpia, Libero, et al.
Publicado: (2007)

A narrative review of MET inhibitors in non-small cell lung cancer with MET exon 14 skipping mutations
por: Santarpia, Mariacarmela, et al.
Publicado: (2021)

Mechanisms of resistance to osimertinib
por: Lazzari, Chiara, et al.
Publicado: (2020)

Capillary leak syndrome induced by neoadjuvant cisplatin and gemcitabine in a patient with bladder cancer
por: Massafra, Marco, et al.
Publicado: (2020)

Immunotherapy of thymic epithelial tumors: molecular understandings and clinical perspectives
por: Ao, Yong-Qiang, et al.
Publicado: (2023)

Exosomal circZNF451 restrains anti-PD1 treatment in lung adenocarcinoma via polarizing macrophages by complexing with TRIM56 and FXR1
por: Gao, Jian, et al.
Publicado: (2022)

Targeting MET in Non-Small Cell Lung Cancer (NSCLC): A New Old Story?
por: Spagnolo, Calogera Claudia, et al.
Publicado: (2023)

Genome-wide discovery of circulating cell-free DNA methylation biomarkers for colorectal cancer detection
por: Fang, Qingxiao, et al.
Publicado: (2023)

Human endogenous retroviruses and cancer
por: Gonzalez-Cao, María, et al.
Publicado: (2016)

Activation of viral defense signaling in cancer
por: Gonzalez-Cao, Maria, et al.
Publicado: (2018)

DNA methylation-based classification and identification of renal cell carcinoma prognosis-subgroups
por: Chen, Wenbiao, et al.
Publicado: (2019)

Osimertinib in the treatment of non-small-cell lung cancer: design, development and place in therapy
por: Santarpia, Mariacarmela, et al.
Publicado: (2017)

Immunotherapy in Early-Stage Non-Small Cell Lung Cancer (NSCLC): Current Evidence and Perspectives
por: Lazzari, Chiara, et al.
Publicado: (2023)

Safety profile of tyrosine kinase inhibitors used in non-small-cell lung cancer: An analysis from the Italian pharmacovigilance database
por: Barbieri, Maria Antonietta, et al.
Publicado: (2022)

The Prognostic Role of Circulating Epstein-Barr Virus DNA Copy Number in Angioimmunoblastic T-Cell Lymphoma Treated with Dose-Adjusted EPOCH
por: Liang, Jin-Hua, et al.
Publicado: (2019)

CTLA-4 silencing in dendritic cells loaded with colorectal cancer cell lysate improves autologous T cell responses in vitro
por: Ghorbaninezhad, Farid, et al.
Publicado: (2022)

Diagnostic and Prognostic Characteristics of Circulating Free DNA Methylation Detected by the Electrochemical Method in Malignant Tumors
por: Sun, Li-Yue, et al.
Publicado: (2021)

Circulating cell-free DNA-based methylation patterns for breast cancer diagnosis
por: Zhang, Xianyu, et al.
Publicado: (2021)

One-third of an Archivial Series of Papillary Thyroid Cancer (Years 2007–2015) Has Coexistent Chronic Lymphocytic Thyroiditis, Which Is Associated with a More Favorable Tumor-Node-Metastasis Staging
por: Ieni, Antonio, et al.
Publicado: (2017)

Detection of epidermal growth factor receptor (EGFR) mutations from preoperative circulating tumor DNA (ctDNA) as a prognostic predictor for stage I–III non-small cell lung cancer (NSCLC) patients with baseline tissue EGFR mutations
por: Guo, Kai, et al.
Publicado: (2021)

Characterising the phenotypic evolution of circulating tumour cells during treatment
por: Tsao, Simon Chang-Hao, et al.
Publicado: (2018)

Characterization of DNA Methylation in Circulating Tumor Cells
por: Pixberg, Constantin F., et al.
Publicado: (2015)

The distribution and function of human memory T cell subsets in lung cancer
por: Sheng, Si Yuan, et al.
Publicado: (2017)

Clinical features and prognostic factors of combined small cell lung cancer: development and validation of a nomogram based on the SEER database
por: Yang, Lan, et al.
Publicado: (2021)

Understanding the function and dysfunction of the immune system in lung cancer: the role of immune checkpoints
por: Karachaliou, Niki, et al.
Publicado: (2015)

Management of Endocrine and Metabolic Toxicities of Immune-Checkpoint Inhibitors: From Clinical Studies to a Real-Life Scenario
por: Spagnolo, Calogera Claudia, et al.
Publicado: (2022)

Targeted therapies for KRAS-mutant non-small cell lung cancer: from preclinical studies to clinical development—a narrative review
por: Santarpia, Mariacarmela, et al.
Publicado: (2023)

The Distribution of Human Stem Cell–like Memory T Cell in Lung Cancer
por: Hong, Hai, et al.
Publicado: (2016)

The independent prokaryotic origins of eukaryotic fructose-1, 6-bisphosphatase and sedoheptulose-1, 7-bisphosphatase and the implications of their origins for the evolution of eukaryotic Calvin cycle
por: Jiang, Yong-Hai, et al.
Publicado: (2012)

Preparation of Poly-(Methyl vinyl ether-co-maleic Anhydride) Nanoparticles by Solution-Enhanced Dispersion by Supercritical CO(2)
por: Chen, Ai-Zheng, et al.
Publicado: (2012)

Epithelial-mesenchymal transition classification of circulating tumor cells in lung and colon cancer patients: potential role in clinical practice
por: Fang, Jinman, et al.
Publicado: (2020)

ASO Author Reflections: Consideration of a Modified Classification System for Gastric Cancer Based on Lauren Subtypes
por: Zhao, Lin-Yong, et al.
Publicado: (2018)

History of Extensive Disease Small Cell Lung Cancer Treatment: Time to Raise the Bar? A Review of the Literature
por: Lazzari, Chiara, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_meag3rbl3subfj5o3d2s75tdur